Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
N. S. Hari Narayana Moorthy, Sergio F. Sousa, Maria J. Ramos & Pedro A. Fernandes. (2011) Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 26:6, pages 777-791.
Read now
Read now
Dario Cattaneo, Sara Baldelli, Simona Merlini, Stefania Zenoni, Norberto Perico & Giuseppe Remuzzi. (2004) Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives. Expert Opinion on Therapeutic Patents 14:11, pages 1553-1566.
Read now
Read now
Articles from other publishers (24)
Steven Fletcher, Erin Pusateri Keaney, Christopher G. Cummings, Michelle A. Blaskovich, Michael A. Hast, Matthew P. Glenn, Sung-Youn Chang, Cynthia J. Bucher, Ryan J. Floyd, William P. Katt, Michael H. Gelb, Wesley C. Van Voorhis, Lorena S. Beese, Said M. Sebti & Andrew D. Hamilton. (2010) Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents. Journal of Medicinal Chemistry 53:19, pages 6867-6888.
Crossref
Crossref
Aijun Lu, Jian Zhang, Xiaojin Yin, Xiaomin Luo & Hualiang Jiang. (2007) Farnesyltransferase pharmacophore model derived from diverse classes of inhibitors. Bioorganic & Medicinal Chemistry Letters 17:1, pages 243-249.
Crossref
Crossref
Wayne C. Guida, Andrew D. Hamilton, Justin W. Crotty & Saïd M. Sebti. (2006) Protein farnesyltransferase: Flexible docking studies on inhibitors using computational modeling. Journal of Computer-Aided Molecular Design 19:12, pages 871-885.
Crossref
Crossref
Laurence Goossens, Sophie Deweer, Jean Pommery, Jean-Pierre Hénichart & Jean-François Goossens. (2005) Spectroscopic study of fluorescent peptides for prenyl transferase assays. Journal of Pharmaceutical and Biomedical Analysis 37:3, pages 417-422.
Crossref
Crossref
Katja Kettler, Jochen Wiesner, Katrin Silber, Peter Haebel, Regina Ortmann, Isabel Sattler, Hans-Martin Dahse, Hassan Jomaa, Gerhard Klebe & Martin Schlitzer. (2005) Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity. European Journal of Medicinal Chemistry 40:1, pages 93-101.
Crossref
Crossref
Andreas Mitsch, Mirko Altenkämper, Isabel Sattler & Martin Schlitzer. (2005) Non‐Thiol Farnesyltransferase Inhibitors: Utilization of the Far Aryl Binding Site by Arylthienylacryloylaminobenzophenones. Archiv der Pharmazie 338:1, pages 9-17.
Crossref
Crossref
Andreas Mitsch, Pia Wißner, Katrin Silber, Peter Haebel, Isabel Sattler, Gerhard Klebe & Martin Schlitzer. (2004) Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides. Bioorganic & Medicinal Chemistry 12:17, pages 4585-4600.
Crossref
Crossref
Andreas Mitsch, Pia Wißner, Markus Böhm, Katrin Silber, Gerhard Klebe, Isabel Sattler & Martin Schlitzer. (2004) Non‐thiol Farnesyltransferase Inhibitors: Utilization of the Far Aryl Binding Site by 5‐Cinnamoylaminobenzophenones. Archiv der Pharmazie 337:9, pages 493-501.
Crossref
Crossref
Xiao-hui Liu & Glenn D. Prestwich. (2004) Didehydrofarnesyl diphosphate: an intrinsically fluorescent inhibitor of protein farnesyltransferase. Bioorganic & Medicinal Chemistry Letters 14:9, pages 2137-2140.
Crossref
Crossref
Andreas Mitsch, Markus Böhm, Isabel Sattler & Martin Schlitzer. (2004) Non‐Thiol Farnesyltransferase Inhibitors: Utilization of the Near Aryl Binding Site by 5‐Arylacetylaminobenzophenones. Archiv der Pharmazie 337:4, pages 213-218.
Crossref
Crossref
Nancy E. Kohl. 2004. Cancer Chemoprevention. Cancer Chemoprevention
303
316
.
Jochen Wiesner, Katja Kettler, Jacek Sakowski, Regina Ortmann, Alejandro M. Katzin, Emília A. Kimura, Katrin Silber, Gerhard Klebe, Hassan Jomaa & Martin Schlitzer. (2003) Farnesyltransferase Inhibitors Inhibit the Growth of Malaria Parasites In Vitro and In Vivo. Angewandte Chemie International Edition 43:2, pages 251-254.
Crossref
Crossref
Jochen Wiesner, Katja Kettler, Jacek Sakowski, Regina Ortmann, Alejandro M. Katzin, Emília A. Kimura, Katrin Silber, Gerhard Klebe, Hassan Jomaa & Martin Schlitzer. (2003) Farnesyltransferase‐Inhibitoren hemmen das Wachstum von Malaria‐Erregern in vitro und in vivo. Angewandte Chemie 116:2, pages 254-257.
Crossref
Crossref
Katsuhiko Iwasaki, Mari Nakatani, Munenori Inoue & Tadashi Katoh. (2003) Synthetic studies of kampanols, novel p21ras farnesyltransferase inhibitors: an efficient synthesis of the tetracyclic ABCD ring system of kampanols. Tetrahedron 59:44, pages 8763-8773.
Crossref
Crossref
Robert B. Lobell, Joseph P. Davide, Nancy E. Kohl, H. Donald Burns, Wai-Si Eng & Raymond E. Gibson. (2003) A Cell-Based Radioligand Binding Assay for Farnesyl: Protein Transferase Inhibitors. SLAS Discovery 8:4, pages 430-438.
Crossref
Crossref
Michael Thutewohl, Lars Kissau, Boriana Popkirova, Ionna-Maria Karaguni, Thorsten Nowak, Michael Bate, Jürgen Kuhlmann, Oliver Müller & Herbert Waldmann. (2003) Identification of mono- and bisubstrate inhibitors of protein farnesyltransferase and inducers of apoptosis from a pepticinnamin E library. Bioorganic & Medicinal Chemistry 11:12, pages 2617-2626.
Crossref
Crossref
Katja Kettler, Jacek Sakowski, Katrin Silber, Isabel Sattler, Gerhard Klebe & Martin Schlitzer. (2003) Non-thiol farnesyltransferase inhibitors: n -(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorganic & Medicinal Chemistry 11:7, pages 1521-1530.
Crossref
Crossref
Stephen L. GwaltneyIIII, Stephen J. O'Connor, Lissa T.J. Nelson, Gerard M. Sullivan, Hovis Imade, Weibo Wang, Lisa Hasvold, Qun Li, Jerome Cohen, Wen-Zhen Gu, Stephen K. Tahir, Joy Bauch, Kennan Marsh, Shi-Chung Ng, David J. Frost, Haiying Zhang, Steve Muchmore, Clarissa G. Jakob, Vincent Stoll, Charles Hutchins, Saul H. Rosenberg & Hing L. Sham. (2003) Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives. Bioorganic & Medicinal Chemistry Letters 13:7, pages 1359-1362.
Crossref
Crossref
M.E DePuy, D.G Musson, S Yu & A.L Fisher. (2002) LC-MS/MS determination of a farnesyl transferase inhibitor in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis 30:4, pages 1157-1171.
Crossref
Crossref
Andreas Mitsch, Markus Böhm, Pia Wißner, Isabel Sattler & Martin Schlitzer. (2002) Non-Thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones. Bioorganic & Medicinal Chemistry 10:8, pages 2657-2662.
Crossref
Crossref
Diem N. Nguyen, Craig A. Stump, Eileen S. Walsh, Christine Fernandes, Joseph P. Davide, Michelle Ellis-Hutchings, Ronald G. Robinson, Theresa M. Williams, Robert B. Lobell, Hans E. Huber & Carolyn A. Buser. (2002) Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters 12:9, pages 1269-1273.
Crossref
Crossref
Douglas C. Beshore & Christopher J. Dinsmore. (2002)
Preparation of Substituted Piperazinones via Tandem Reductive Amination−(
N
,
N
‘-Acyl Transfer)−Cyclization
. Organic Letters 4:7, pages 1201-1204.
Crossref
Crossref
Douglas C Beshore, Ian M Bell, Christopher J Dinsmore, Carl F Homnick, J.Christopher Culberson, Ronald G Robinson, Christine Fernandes, Eileen S Walsh, Marc T Abrams, Hema G Bhimnathwala, Joseph P Davide, Michelle S Ellis-Hutchings, Hans A Huber, Kenneth S Koblan, Carolyn A Buser, Nancy E Kohl, Robert B Lobell, I-Wu Chen, Debra A McLoughlin, Timothy V Olah, Samuel L Graham, George D Hartman & Theresa M Williams. (2001) Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters 11:14, pages 1817-1821.
Crossref
Crossref
Jeffrey M Bergman, Marc T Abrams, Joseph P Davide, Ian B Greenberg, Ronald G Robinson, Carolyn A Buser, Hans E Huber, Kenneth S Koblan, Nancy E Kohl, Robert B Lobell, Samuel L Graham, George D Hartman, Theresa M Williams & Christopher J Dinsmore. (2001) Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters 11:11, pages 1411-1415.
Crossref
Crossref